Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Liver cancer, adult primary
Stage/Subtype:  localized resectable adult primary liver cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-7 of 7 for your search:
Start Over
PET/CT in Diagnosing Patients with Liver Cancer Undergoing Surgical Resection
Status: Active
Phase: Phase II
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: RA-2011-025, NCI-2012-02095, CHS-19373, NCT01395030
Sorafenib Tosylate following a Liver Transplant in Treating Patients with Liver Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 11-003311, NCI-2012-00911, JCCC-SUPPL-8-2014, ONC-2010-31, NCT01624285
Temsirolimus and Sorafenib Tosylate in Treating Patients With Stage II-IV Liver Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 85
Trial IDs: 124511, NCI-2012-02021, NCT01687673
Chemoembolization with Doxorubicin Hydrochloride-Eluting Beads in Treating Patients with Liver Cancer Who Are Being Considered for Liver Transplant
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 124520, NCI-2015-00697, CC# 124520, UCSF CC#124520, 082078, DEB-TACE, NCT02147301
Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9008, NCI-2012-01040, NA_00052587, NCI-2013-01545, CDR0000737061, J11105, NCT01638533
Gefitinib in Treating Patients With Newly Diagnosed Liver Cancer That Can Be Removed By Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: JS0414, NCI-2011-00087, NCT00282100
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients with Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Start Over